Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 27;38(1):6.
doi: 10.1007/s11274-021-03182-4.

Biochanin A as an α-hemolysin inhibitor for combating methicillin-resistant Staphylococcus aureus infection

Affiliations

Biochanin A as an α-hemolysin inhibitor for combating methicillin-resistant Staphylococcus aureus infection

Jiaxuan Feng et al. World J Microbiol Biotechnol. .

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a multidrug-resistant pathogen that poses a significant risk to global health today. In S. aureus, α-hemolysin is an important virulence factor as it contributes to the capacity of the bacteria to infect the host. Here, we showed that biochanin A (bioA), an isoflavone present in red clover, cabbage and alfalfa, effectively inhibited hemolytic activity at a dose as low as 32 μg/mL. Further, western blot and RT-qPCR data showed that bioA reduced the production and expression of MRSA hemolysin in a dose-dependent manner. In addition, when different concentrations of bioA were added to a coculture system of A549 cells and S. aureus, it could significantly decrease cell injury. Importantly, the in vivo study showed that bioA could protect mice from pneumonia caused by a lethal dose of MRSA, as evidenced by improving their survival and reducing the number of bacterial colonies in lung tissues, the secretion of hemolysin into alveolar lavage fluid and the degree of pulmonary edema. In conclusion, biochanin A protected the host from MRSA infection by inhibiting the expression of the hemolysin of MRSA, which may provide experimental evidence for its development to a potential anti-MRSA drug.

Keywords: Antivirulence; Biochanin A; Methicillin-resistant Staphylococcus aureus; α-Hemolysin.

PubMed Disclaimer

References

    1. Bernheimer AW, Schwartz LL (1963) Isolation and composition of staphylococcal alpha toxin. J Gen Microbiol 30:455–468. https://doi.org/10.1099/00221287-30-3-455 - DOI - PubMed
    1. Berube BJ, Bubeck Wardenburg J (2013) Staphylococcus aureus α-toxin: nearly a century of intrigue. Toxins 5(6):1140–1166. https://doi.org/10.3390/toxins5061140 - DOI - PubMed - PMC
    1. Bhakdi S, Muhly M, Füssle R (1984) Correlation between toxin binding and hemolytic activity in membrane damage by staphylococcal alpha-toxin. Infect Immun 46(2):318–323. https://doi.org/10.1128/iai.46.2.318-323.1984 - DOI - PubMed - PMC
    1. Brown EL, Dumitrescu O, Thomas D, Badiou C, Koers EM, Choudhury P, Vazquez V, Etienne J, Lina G, Vandenesch F, Bowden MG (2009) The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin Microbiol Infect 15(2):156–164. https://doi.org/10.1111/j.1469-0691.2008.02648.x - DOI - PubMed - PMC
    1. Bubeck Wardenburg J, Patel RJ, Schneewind O (2007) Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect Immun 75(2):1040–1044. https://doi.org/10.1128/iai.01313-06 - DOI - PubMed

MeSH terms

LinkOut - more resources